Simple and convenient chromatography-based methods for purifying the pseudovirus of human papillomavirus type 58

Protein Expression and Purification

Volumn 76, Issue 1, 2011, Pages 103-108

  Kim, So Young ^a   Kim, Hyoung Jin ^a   Kim, Hong Jin ^a  

^a Chung Ang University   (South Korea)

Author keywords

Heparin chromatography; HPV type 58; Papillomavirus; Pseudovirus; Purification

Indexed keywords

ANIMAL; ARTICLE; CELL LINE; DENSITY GRADIENT CENTRIFUGATION; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MOUSE; ULTRASTRUCTURE; VIRION;

ANIMALS; CELL LINE; CENTRIFUGATION, DENSITY GRADIENT; CHROMATOGRAPHY, ION EXCHANGE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; VIRION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 58; PAPILLOMAVIRIDAE;

EID: 78650173483     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.11.003     Document Type: Article

References (38)

1. S. Ljubojevic The human papillomavirus vaccines Acta Dermatovenerol. Croat. 14 2006 208
2. N.H. Jeong, N.W. Lee, M.K. Woo, and H.J. Kim Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions Arch. Pharm. Res. 32 2009 383 389
3. N.H. Jeong, M.K. Woo, N.W. Lee, S.J. Hur, K.S. Choi, and H.J. Kim Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer Arch. Pharm. Res. 32 2009 1013 1018
4. L. Schadlich, T. Senger, C.J. Kirschning, M. Muller, and L. Gissmann Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity Vaccine 27 2009 1511 1522
5. G.M. Clifford, J.S. Smith, T. Aguado, and S. Franceschi Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis Br. J. Cancer 89 2003 101 105 (Pubitemid 36897943)
6. P.K. Chan, W.H. Li, M.Y. Chan, W.L. Ma, J.L. Cheung, and A.F. Cheng High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions J. Med. Virol. 59 1999 232 238 (Pubitemid 29407287)
7. Y.P. Bao, N. Li, J.S. Smith, and Y.L. Qiao Human papillomavirus type distribution in women from Asia: a meta-analysis Int. J. Gynecol. Cancer 18 2008 71 79
8. H. Hara, A. Honda, H. Suzuki, T. Sata, and T. Matsukura Detection of human papillomavirus type 58 in polydactylous Bowen's disease on the fingers and toes of a woman - concurrent occurrence of invasive vulval and cervical carcinomas Dermatology 209 2004 218 222 (Pubitemid 39370331)
9. T. Zhang, Y. Xu, L. Qiao, Y. Wang, X. Wu, D. Fan, Q. Peng, and X. Xu Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types Vaccine 28 2010 3479 3487
10. A. Touze, S. de Sanjose, P. Coursaget, M.R. Almirall, V. Palacio, C.J. Meijer, J. Kornegay, and F.X. Bosch Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes J. Clin. Microbiol. 39 2001 4344 4348 (Pubitemid 33117121)
11. C. Meyers, M.G. Frattini, J.B. Hudson, and L.A. Laimins Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation Science 257 1992 971 973
12. M.J. Conway, and C. Meyers Replication and assembly of human papillomaviruses J. Dent. Res. 88 2009 307 317
13. M. Sapp, and M. Bienkowska-Haba Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus Febs. J. 276 2009 7206 7216
14. C.B. Buck, D.V. Pastrana, D.R. Lowy, and J.T. Schiller Efficient intracellular assembly of papillomaviral vectors J. Virol. 78 2004 751 757 (Pubitemid 38067597)
15. T. Letian, and Z. Tianyu Cellular receptor binding and entry of human papillomavirus Virol. J. 7 2010 2
16. J.E. Han, H.K. Kim, S.A. Park, S.J. Lee, H.J. Kim, G.H. Son, Y.T. Kim, Y.J. Cho, H.J. Kim, and N.G. Lee A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil HPV vaccine in mice Int. Immunopharmacol. 10 2010 169 176
17. S.N. Kim, H.S. Jeong, S.N. Park, and H.J. Kim Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae J. Virol. Methods 139 2007 24 30 (Pubitemid 44872904)
18. D.V. Pastrana, C.B. Buck, Y.Y. Pang, C.D. Thompson, P.E. Castle, P.C. FitzGerald, S. Kruger Kjaer, D.R. Lowy, and J.T. Schiller Reactivity of human sera in a sensitive high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18 Virology 321 2004 205 216 (Pubitemid 38406035)
19. B. Bishop, J. Dasgupta, M. Klein, R.L. Garcea, N.D. Christensen, R. Zhao, and X.S. Chen Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies J. Biol. Chem. 282 2007 31803 31811 (Pubitemid 350044858)
20. C.B. Buck, C.D. Thompson, Y.Y. Pang, D.R. Lowy, and J.T. Schiller Maturation of papillomavirus capsids J. Virol. 79 2005 2839 2846 (Pubitemid 40270562)
21. X.S. Chen, R.L. Garcea, I. Goldberg, G. Casini, and S.C. Harrison Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 Mol. Cell 5 2000 557 567
22. C.B. Buck, N. Cheng, C.D. Thompson, D.R. Lowy, A.C. Steven, J.T. Schiller, and B.L. Trus Arrangement of L2 within the papillomavirus capsid J. Virol. 82 2008 5190 5197 (Pubitemid 351705228)
23. R. Yang, C.M. Wheeler, X. Chen, S. Uematsu, K. Takeda, S. Akira, D.V. Pastrana, R.P. Viscidi, and R.B. Roden Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer J. Virol. 79 2005 6741 6750 (Pubitemid 40677305)
24. R. Gambhira, B. Karanam, S. Jagu, J.N. Roberts, C.B. Buck, I. Bossis, H. Alphs, T. Culp, N.D. Christensen, and R.B. Roden A protective and broadly cross-neutralizing epitope of human papillomavirus L2 J. Virol. 81 2007 13927 13931 (Pubitemid 350247886)
25. Y.F. Xu, Y.Q. Zhang, X.M. Xu, and G.X. Song Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes Arch. Virol. 151 2006 2133 2148
26. M.J. Conway, S. Alam, E.J. Ryndock, L. Cruz, N.D. Christensen, R.B. Roden, and C. Meyers Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions J. Virol. 83 2009 10515 10526
27. V. Madrid-Marina, K. Torres-Poveda, G. Lopez-Toledo, and A. Garcia-Carranca Advantages and disadvantages of current prophylactic vaccines against HPV Arch. Med. Res. 40 2009 471 477
28. D. Opalka, K. Matys, P. Bojczuk, T. Green, R. Gesser, A. Saah, R. Haupt, F. Dutko, and M.T. Esser Multiplexed serologic assay for nine anogenital human papillomavirus types Clin. Vaccine Immunol. 17 2010 818 827
29. S. Jagu, B. Karanam, R. Gambhira, S.V. Chivukula, R.J. Chaganti, D.R. Lowy, J.T. Schiller, and R.B. Roden Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines J. Natl. Cancer Inst. 101 2009 782 792
30. K. Kondo, Y. Ishii, H. Ochi, T. Matsumoto, H. Yoshikawa, and T. Kanda Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region Virology 358 2007 266 272 (Pubitemid 46136425)
31. M. Knappe, S. Bodevin, H.C. Selinka, D. Spillmann, R.E. Streeck, X.S. Chen, U. Lindahl, and M. Sapp Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate J. Biol. Chem. 282 2007 27913 27922 (Pubitemid 47529517)
32. H.J. Kim, S.Y. Kim, S.J. Lim, J.Y. Kim, S.J. Lee, and H.J. Kim One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae Protein Expr. Purif. 70 2010 68 74
33. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
34. M.A. Park, H.J. Kim, and H.J. Kim Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae Protein Expr. Purif. 59 2008 175 181
35. M.K. Woo, J.M. An, J.D. Kim, S.N. Park, and H.J. Kim Expression and purification of human papillomavirus 18 L1 virus-like particle from Saccharomyces cerevisiae Arch. Pharm. Res. 31 2008 205 209
36. G. Bird, M. O'Donnell, J. Moroianu, and R.L. Garcea Possible role for cellular karyopherins in regulating polyomavirus and papillomavirus capsid assembly J. Virol. 82 2008 9848 9857
37. R.C. Kines, C.D. Thompson, D.R. Lowy, J.T. Schiller, and P.M. Day The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding Proc. Natl. Acad. Sci. USA 106 2009 20458 20463
38. P.M. Day, R. Gambhira, R.B. Roden, D.R. Lowy, and J.T. Schiller Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies J. Virol. 82 2008 4638 4646 (Pubitemid 351563700)